BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15661273)

  • 21. [Reappearance of t(12;17)-positive primary myelofibrosis following Ph+ CML cell reduction by imatinib].
    Araki N; Takimoto R; Fujimi A; Murase K; Araki H; Takahira N; Matsunaga T; Terui T; Kogawa K; Hirayama Y; Kato J; Niitsu Y
    Rinsho Ketsueki; 2007 Jun; 48(6):518-23. PubMed ID: 17633103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imatinib resistant chronic myelogenous leukemia, BCR-ABL positive by chromosome and FISH analyses but negative by PCR, in a child progressing to acute basophilic leukemia: cytogenetic follow-up.
    Moser AM; Manor E; Narkis G; Kapelushnik J
    Cancer Genet Cytogenet; 2006 Oct; 170(1):54-7. PubMed ID: 16965955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A complex translocation (9;22;16)(q34;q11.2;p13) in chronic myelocytic leukemia.
    Espinoza JP; Cárdenas VJ; Jiménez EA; Angulo MG; Flores MA; García JR
    Cancer Genet Cytogenet; 2005 Mar; 157(2):175-7. PubMed ID: 15721642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple myeloma and renal transplant.
    Cacciola E; Giustolisi R; Guglielmo P; Cacciola E
    Haematologica; 1994; 79(1):73-5. PubMed ID: 15378953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of BCR/ABL transcript variants with patients' characteristics in childhood chronic myeloid leukaemia.
    Adler R; Viehmann S; Kuhlisch E; Martiniak Y; Röttgers S; Harbott J; Suttorp M
    Eur J Haematol; 2009 Feb; 82(2):112-8. PubMed ID: 19067742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF.
    Siebolts U; Thiele J; Zander T; Ditschkowski M; Beelen DW; Kröger N; Fehse B; Wickenhauser C
    Oncol Rep; 2008 Jan; 19(1):287-92. PubMed ID: 18097609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linear IgA dermatosis in an immunosuppressed patient after allogenic bone marrow transplantation.
    Schultewolter T; Goos M; Dissemond J
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):721-5. PubMed ID: 15482308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation.
    Nouri-Majelan N; Sanadgol H; Ghafari A; Rahimian M; Najafi F; Mortazavizadeh M; Moghaddasi S
    Transplant Proc; 2005 Sep; 37(7):3213-5. PubMed ID: 16213351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
    Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case of adult mumps infection after renal transplantation.
    Park SB; Jin KB; Hwang EA; Han SY; Kim HC; Kim HT; Cho WH; Kwak JH; Ahn KS
    Transplant Proc; 2008 Sep; 40(7):2442-3. PubMed ID: 18790262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of CD7 on CD34+ cells is not linked to deletion of derivative chromosome 9 or lack of dendritic cells in chronic myeloid leukaemia.
    Fløisand Y; Normann AP; Heim S; Lund-Johansen F; Tjønnfjord GE
    Scand J Clin Lab Invest; 2008; 68(2):93-8. PubMed ID: 17852828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute myelogenous leukaemia after renal transplantation (author's transl)].
    Leithner C; Kübböck J; Winterleitner H; Pavelka M; Krisch K
    Acta Med Austriaca; 1981; 8(2):29-33. PubMed ID: 7025546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells.
    Brauer KM; Werth D; von Schwarzenberg K; Bringmann A; Kanz L; Grünebach F; Brossart P
    Cancer Res; 2007 Jun; 67(11):5489-97. PubMed ID: 17545631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-transplantation chronic myeloid leukemia.
    le Coutre P; Schwarz M; Daniel P; Dörken B
    Clin Adv Hematol Oncol; 2011 Aug; 9(8):627-9. PubMed ID: 22236992
    [No Abstract]   [Full Text] [Related]  

  • 36. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36).
    Oren H; Yilmaz S; Sercan Z; Demircioğlu F; Yüksel E; Irken G
    Cancer Genet Cytogenet; 2008 Apr; 182(1):43-5. PubMed ID: 18328950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
    Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
    Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; Pastwińska A; Konopka L; Majewski M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.
    Schmitt M; Li L; Giannopoulos K; Chen J; Brunner C; Barth T; Schmitt A; Wiesneth M; Döhner K; Döhner H; Greiner J
    Exp Hematol; 2006 Dec; 34(12):1709-19. PubMed ID: 17157168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects.
    Butt NM; Rojas JM; Wang L; Christmas SE; Abu-Eisha HM; Clark RE
    Haematologica; 2005 Oct; 90(10):1315-23. PubMed ID: 16219567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.